PRESSUREWIRE™ X GUIDEWIRE FOR IMPROVED CARDIAC CATH LAB WORKFLOW
Using existing hardware and screens, the PressureWire™ X Guidewire displays FFR or RFR measurements in the cardiac cath lab as well as the control room. All FFR/RFR results are stored with procedural data to provide a complete patient record.
In addition, the PressureWire™ X Guidewire requires no stand-alone FFR/RFR instrumentation or time-consuming setup. The secure, wireless technology eliminates cables crossing the sterile field, and there is no cable to limit wire maneuverability.
This newest generation of PressureWire™ X Guidewire technology offers:
- Four connectivity options to measure both FFR and RFR
- A hydrophilic coating that significantly lowers friction and enables smoother stent delivery and better overall maneuverability1
- Improved shapeability and reshapeability for smooth navigation1
- Better shape retention for performance in complex anatomy and for multiple pull-backs1
- More durable soft tip designed to protect the vessel in tortuous anatomy without compromising steerability/trackability1
- Wireless technology for ease of use when employing a radial approach
- Drift reduction, which can minimize drift and therefore operator error for FFR/RFR measurements2
ACCURATE AND RELIABLE
The PressureWire™ X Guidewire is the only pressure wire technology clinically proven in both FAME and FAME 2 studies.3-5
1. Data on file at Abbott
2. Compared to the previous generation (PressureWire™ 8 Guidewire); Abbott data on file.
3. Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary iIntervention. New Engl J Med. 2009;360:213-224. doi: 10.1056/NEJMoa0807611.
4. Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME study. J Am Coll Cardiol. 2010;56(3):177-184. doi: 10.1016/j.jacc.2010.04.012.
5. de Bruyne B, et al. Fractional flow reserve–guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367(11), 991–1001. doi: 10.1056/NEJMoa1205361.